Collagen Decline Affects More Than Just Your Skin
What gives? Well, collagen: the protein shaping your face, bracing your joints and bolstering your hair from the root, which begins to decline in production during your mid-20s.
So it's no wonder collagen is having a moment. We're stirring it into coffee, sipping it between meetings, popping tablets of it like candy.
What is collagen?
Collagen is the most abundant protein in our bodies. Think of it as the biological glue that keeps your features firm, your body upright, and your bounce intact. Humans have at least 28 types, but Types I, II and III are the headliners:
Type I: Skin, bones, tendons, ligaments, accounts for 90% of the body's collagen
Skin, bones, tendons, ligaments, accounts for 90% of the body's collagen Type II: Cartilage and joints
Cartilage and joints Type III: Skin, blood vessels, internal organs
Your body makes collagen by combining amino acids from protein-rich foods with help from vitamin C, zinc, and copper. But from your mid-to-late twenties onwards, production begins to dip by about 1% a year.
As Dr Rinky Kapoor, consultant dermatologist at The Esthetic Clinics, tells Vogue: 'The decrease is 1% every year post your 20s, and when you reach your 40s, the production dwindles even further, displaying signs of ageing.'
What does collagen decline look like on the outside?
Skin: Less bounce, more sag
Collagen gives skin its structure and firmness. As levels drop, you start noticing:
Fine lines and wrinkles (the classics)
Loss of elasticity and plumpness
Dryness, dullness and slower wound healing
'The collagen in our skin reflects a delicate equilibrium between synthesis and degradation,' Mercedes Abarquero Cerezo, pharmacist and head of scientific projects at L'Oréal Dermatological Beauty Spain, says. 'As we age, the cells responsible for collagen production slow down. At the same time, a host of external and internal factors—from sun exposure and diet to stress and hormonal shifts, particularly during menopause—can speed up its breakdown.'

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
2 hours ago
- Yahoo
CDC warns travelers about chikungunya cases in China as global infections hit 240,000
U.S. health officials are cautioning travelers about a mosquito-borne illness being transmitted in parts of Asia, South America, Africa and the Indian Ocean. Across the globe, the chikungunya virus has sparked 240,000 cases and 90 deaths in 2025, according to the European Centre for Disease Prevention and Control. The virus, which is infecting people through bites from Aedes mosquitoes, has been spreading in China's Guangdong province this summer. Health officials reported the area has seen over 7,000 confirmed cases since June. The U.S. Centers for Disease Control and Prevention (CDC) this month issued a travel notice for the Guangdon province in China, encouraging travelers to practice enhanced precautions. The agency issued the same notices for other countries where outbreaks have been reported, including Bolivia, Kenya, Madagascar, Mauritius, Mayotte, Réunion, Somalia and Sri Lanka. The CDC is also asking U.S. residents to exercise caution when visiting the following countries, which have not yet reported an outbreak but are at elevated risk of exposure: Brazil, Colombia, Mexico, India, Pakistan, Philippines, Thailand and Nigeria. According to the World Health Organization (WHO), 5.6 billion people are at risk of arboviral diseases such as chikungunya. Other widespread arboviruses impacting humans include dengue, Zika and yellow fever. What are the symptoms of chikungunya? Symptoms of the disease include fever, joint pain and swelling, headache, muscle pain and rash, according to the CDC. How long does infection last? The illness typically lasts between two to 12 days after infection. Some patients can experience extreme symptoms and the virus can be fatal. Elderly people, newborns and individuals with underlying medical conditions are at higher risk of medical intervention. Severe complications, including cardiovascular, neurological and multiorgan involvement, may require intensive medical care, according to the WHO. However, more than half of patients will experience symptoms commonly associated with a fever. What treatments are available? There are no known antiviral treatments for the illness. Medications can be used to manage pain and fever. Two chikungunya vaccines have received regulatory approval but are not widely available. In May, federal officials recommended pausing a vaccine in the United States after reports of serious adverse events. The illness was first discovered in Tanzania in 1952, with outbreaks being reported in Africa and Asia, according to the WHO. Since then, the virus has been transmitted to 119 countries. Last year, more than 620,000 and 213 deaths were reported globally, according to the European Centre for Disease Prevention and Control. In what was then dubbed the largest documented outbreak of chikungunya, an estimated several hundred thousand people were affected by "explosive" outbreaks of the virus in the Indian Ocean islands and India, according to a 2008 study. It's estimated that about 60 percent of regional populations were exposed. CDC issues travel notice for Americans The CDC issued a travel warning on Friday, Aug. 1, advising U.S. residents to take enhanced precautions when traveling to China. Most of the country's cases have been reported in the city of Foshan. Last month, Chinese officials held a national conference to discuss treatments for and prevention of the illness. Authorities agreed to continue monitoring the situation and issue early warnings through multiple channels to prevent further spreading, according to China's National Health Commission. Michelle Del Rey is a trending news reporter at USA TODAY. Contact her at mdelrey@ This article originally appeared on USA TODAY: Chikungunya virus cases reported in China prompt CDC travel notice
Yahoo
2 hours ago
- Yahoo
Bracco Imaging Receives Regulatory Approval in China for SonoVue® in the Assessment of Fallopian Tube Patency
New indication of SonoVue® supports non-invasive assessment of female infertility through contrast-enhanced ultrasound in China MILAN, Aug. 6, 2025 /PRNewswire/ -- Bracco Imaging, a global leader in diagnostic imaging, today announced that its ultrasound contrast agent SonoVue® has been approved by the China's National Medical Products Administration (NMPA) for use in hysterosalpingo contrast sonography (HyCoSy). HyCoSy is a contrast-enhanced ultrasound (CEUS) procedure that helps identifying potential causes of female infertility related to blockage of the fallopian tubes or uterine abnormalities with a high level of diagnostic accuracy (1,2). Fallopian tube conditions, such as blockages, scarring, or other damage, are a leading cause of infertility, contributing to approximately 25–35 percent of cases of infertility among women in China (3). This regulatory approval represents an important milestone in the management of infertility because, unlike laparoscopic assessment of tubal patency with use of a dye, HyCoSy is a non-invasive procedure, and, unlike traditional X-ray hysterosalpingography, HyCosy does not expose to radiation the genital tract of women in their reproductive years (4-6). "The NMPA approval of SonoVue® use with HyCoSy marks an important step in expanding access to non-invasive, radiation-free detection of tubal issues and uterine problems that often cause infertility in women," said Alberto Spinazzi, Chief Medical and Regulatory Officer, Bracco Group. "We strive to provide healthcare professionals in China with solutions that advance standards of care, reflecting our commitment to advancing diagnostic precision and improving the patient experience through contrast-enhanced ultrasound." "We are proud to support China's healthcare priorities through solutions like SonoVue® that may help address important diagnostic needs," said Valtero Canepa, Head of APAC, Bracco Imaging. "This new indication advances Bracco's role in delivering meaningful innovation in support of the Healthy China 2030 initiative, which prioritizes earlier detection, clinical precision, and broader access to reproductive health services." The high diagnostic performance of HyCoSy with SonoVue® has been confirmed by a recent systematic review and meta-analysis of 24 clinical studies (total of 1358 women with infertility and 2661 fallopian tubes). Using laparoscopic chromotubation dye test as the standard of truth for the assessment of fallopian tube patency, the pooled estimates of sensitivity, specificity, and accuracy of HyCoSy with SonoVue® were 93%, 90%, and 96%, respectively (1). Backed by over 20 years of clinical use, SonoVue® is the ultrasound contrast agent with the largest number of approved indications in the largest number of countries worldwide. The newly approved HyCoSy indication reinforces Bracco Imaging's commitment to expanding non-invasive, high-quality diagnostic tools aligned with evolving clinical standards and national health objectives in China and beyond. Qu E, Zhang M, Ju J, Chen Y, Lin X, Zhang X. Is Hysterosalpingo-Contrast Sonography (HyCoSy) Using Sulfur Hexafluoride Microbubbles (SonoVue) Sufficient for the Assessment of Fallopian Tube Patency? A Systematic Review and Meta-Analysis. J Ultrasound Med 2023; 42:7-15 Wang T, Dong T, Nie F. Clinical applications, advances, and future directions in hysterosalpingography. Front Med 2025; 12:1537506 Reproductive Health Branch of Chinese Preventive Medicine Association. Chinese Expert Consensus on Holistic Management of Tubal Factor Infertility (2023 edition) [J]. Chinese Journal of Practical Gynecology and Obstetrics 2023; 39:318-324 Roy KK, Gajapathy SR, Rai R, Zangmo R, Das A, Singhal S. Assessment of Tubal Patency with Selective Chromopertubation at Office Hysteroscopy versus Modified Minilaparoscopy in Infertile Women. Gynecol Minim Invasive Ther 2021; 10:159-165 Perisinakis K, Damilakis J, Grammatikakis J, Theocharopoulos N, Gourtsoyiannis N. Radiogenic risks from hysterosalpingography. Eur Radiol 2003; 13:1522-1528 Sulieman A, Theodorou K, Vlychou M, Topaltzikis T, Roundas C, Fezoulidis I, Kappas C. Radiation dose optimisation and risk estimation to patients and staff during hysterosalpingography. Radiat Prot Dosimetry 2008;128:217-226 For additional information about Bracco's products, and for full prescribing information, please visit About Bracco ImagingBracco Imaging S.p.A. ("Bracco Imaging"), part of the Bracco Group, is an innovative world leader delivering end-to-end products and solutions through its comprehensive portfolio across diagnostic imaging modalities. Headquartered in Milan, Italy, Bracco Imaging's purpose is to improve people's lives by shaping the future of prevention and precision diagnostic imaging. The Bracco Imaging portfolio includes products and solutions for all key diagnostic imaging modalities: X-ray imaging, magnetic resonance imaging (MRI), Contrast Enhanced Ultrasound (CEUS), and Nuclear Medicine through radioactive tracers and novel PET imaging agents. Bracco Imaging has 3,800 employees and operates in more than 100 markets globally. Bracco Imaging has a well skilled and innovative Research and Development (R&D) organization with an efficient process-oriented approach and track record in the diagnostic imaging industry. Discover Bracco at Media Contacts: Bracco Press Contact:Carolina BargoniBracco Imaging, Communications 347 5397738 SOURCE Bracco Imaging
Yahoo
5 hours ago
- Yahoo
When does the body really start aging? The answer may surprise you.
When does aging really shift into overdrive? A new study suggests it may be sooner than you think. Scientists at the Chinese Academy of Sciences studied proteins in tissue taken from about 70 people ages 14 to 68, according to the study published July 25 in the journal Cell. These proteins give scientists a window of when the aging process may begin on a cellular level, said Dr. Thomas Blackwell, associate dean for graduate medical education and professor of medicine at the University of Texas Medical Branch. Proteins are created in a 'factory' using instructions from messenger RNA, he said. A sign of aging is when the cells' ability to make proteins correctly and efficiently starts to break down. By looking at tissues taken from organs throughout the body, including the heart, liver, pancreas, spleen, lung, skin and muscles, researchers determined that aging starts to accelerate from 45 to 55. They also found that organs aged at different rates. For example, the spleen, aorta (the body's main artery) and adrenal gland (responsible for producing hormones) showed signs of aging at around 30. The aorta also saw the biggest changes in protein levels around the ages of 45 and 55. 'This is just a beautiful roadmap that gives us an initial overview of organ aging,' said Neville Sanjana, associate professor of biology, neuroscience and physiology at New York University and a faculty member at the New York Genome Center. The study's findings could have a lot of implications in future research into treatments for chronic conditions related to aging that would not only add decades to patients' lifespan, but also their health span, which is the period of a person's life spent in good health, he said. 'To me, that's exciting,' Sanjana said. 'This kind of data generation is so powerful for folks who want to do things like bioengineering and creating new kinds of therapies to restore healthy aging.' For Blackwell, the study also shows that patients still have the chance to change their aging trajectory later in life – 'but the window is short,' he said. The best ways to add healthy years to your life are to maintain a healthy level of blood pressure, blood sugar and cholesterol, don't smoke and drink "very little," Blackwell said. Research has shown diet, exercise, genetics and, sometimes, luck, impact longevity. However, the new study suggests people may still see benefits from changes later in life. 'Starting at 45 to 50, you could gain as much as 10 years of healthy life and this study just shows the truth of that at a cellular level,' he said. Adrianna Rodriguez can be reached at adrodriguez@ This article originally appeared on USA TODAY: Aging: Body starts changing after 50. Here's what happens. Solve the daily Crossword